Condition

Obesity Hypoventilation Syndrome

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 43 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials43

Recruiting0

Common interventions25

Lead sponsors shown15

Clinical trials

43 shown

The Effect of Obesity Hypoventilation Syndrome on Exercise Capacity, Peripheral Muscle Strength, and Quality of Life in Obese IndividualsNCT06142513 · 2024-04-10

Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap SyndromeNCT05190458 · 2023-03-01

Obesity-hypoventilation in Metabolic Syndrom PatientsNCT04839419 · 2020-08-01

Randomized Controlled Trial Between Auto-titration and Manual Titration of Non-invasive Ventilation in Obesity Hypoventilation SyndromeNCT04327336 · 2020-04-01

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in ObesityNCT04100616 · 2020-03-02

Ketogenic Diet for Obesity Hypoventilation SyndromeNCT04108819 · 2019-10-30

Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory DiseasesNCT04098094 · 2019-09-19

Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS )NCT03861468 · 2019-09-14

Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the DiseaseNCT03854058 · 2019-05-01

Microbiologic Contamination of Home Non Invasive VentilatorsNCT03809832 · 2019-01-21

The Debated Role of Sleep Studies in Patients Under Established Home Mechanical VentilationNCT03506906 · 2018-11-11

Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective StudyNCT03572712 · 2018-08-14

Effects of PEEP on Heart and Lungs in Obese SubjectsNCT02523352 · 2018-04-05

Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory FailureNCT03353064 · 2017-10-18

Postoperative Complications in Patients With Obesity Hypoventilation SyndromeNCT02980770 · 2016-11-01

Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis PlatformNCT03085537 · 2016-10-01

Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - GermanyNCT02726048 · 2016-04-01

Myocardial Effects of NIV in OHS PatientsNCT06486129 · 2016-03-01

Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)NCT02486380 · 2015-07-01

Juno Perth Clinical TrialNCT02317042 · 2015-05-29

Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory FailureNCT02342899 · 2015-03-01

Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered BreathingNCT02368639 · 2015-01-01

Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care UnitsNCT02934581 · 2014-10-29

European Home Mechanical Ventilation RegistryNCT02315339 · 2014-08-01

Obesity Hypoventilation Syndrome Prevalence StudyNCT01964339 · 2013-10-09

Prevalence of Obesity Hypoventilation SyndromeNCT01903135 · 2013-09-01

Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHSNCT01757444 · 2013-06-01

Target Volume in Noninvasive Positive Pressure VentilationNCT01748656 · 2013-01-01

Ventilator Monitoring in Early Exacerbation DetectionNCT01644162 · 2012-07-01

Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive VentilationNCT01560741 · 2012-07-01

A Study to Investigate the Effects of Heated Humidification During Non-Invasive VentilationNCT01372072 · 2012-02-01

Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.NCT01499485 · 2011-11-01

A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)NCT01483716 · 2011-11-01

AVAPS-AE Efficacy StudyNCT01368614 · 2011-09-12

Treatment for Obstructive Sleep Apnea Hypopnea Syndrome and Obesity Hypoventilation Syndrome (OHS)NCT01553227 · 2011-08-01

Factors Associated With Chronic Respiratory Failure in ObesityNCT01380418 · 2011-06-01

Patient -Ventilator Interaction in Chronic Respiratory FailureNCT01371149 · 2011-01-01

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory FailureNCT01174316 · 2010-08-01

PAP Therapy in Patients With Obesity Hypoventilation SyndromeNCT03449641 · 2009-06-01

Target Volume Mode Controlled Ventilator in Obesity Hypoventilation SyndromeNCT01104610 · 2009-05-01

Alternative of Treatment in Obesity Hypoventilation SyndromeNCT01405976 · 2009-05-01

Efficacy of Average Volume Assured Pressure Support With Bi-Level Pressure Support Nocturnal VentilationNCT00479284 · 2006-06-01

The Obesity-hypoventilation Syndrome Study of Clinical Characteristics and Predictive Factors of Response to TreatmentNCT00938977 · 2003-06-01

Common interventions

AcetazolamideDRUG1 AssessmentOTHER1 Automatic Non invasive ventilation titrationDEVICE1 AutoVPAP™DEVICE1 AVAPSDEVICE1 AVAPS-AE Mode of TherapyDEVICE1 Average volume assured pressure support (AVAPS)PROCEDURE1 Bilevel Support Ventilation (Non-Invasive Ventilation)DEVICE1 BiPAP - A40DEVICE1 BiPAP - STDEVICE1 Blood test analysis in the clinical labsPROCEDURE1 BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.OTHER1 BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.OTHER1 Breas Vivo 40DEVICE1 Care pathwayOTHER1 CPAPDEVICE1 EMSOTHER1 Esophageal catheter positioningPROCEDURE1 Fisher & Paykel Healthcare PAP DeviceDEVICE1 High Velocity Nasal InsufflationOTHER1 Inpatient NIV Set Up using spontaneous/timed (S/T) mode pressure support ventilation (Manufactured by Philips-Respironics)DEVICE1 IVAPSDEVICE1 iVAPS ventilationDEVICE1 JunoDEVICE1 Ketogenic DietDIETARY_SUPPLEMENT1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

acetazolamide1 placebo1

Leading sponsors

ResMed 4 Fisher and Paykel Healthcare 3 Guy's and St Thomas' NHS Foundation Trust 3 AGIR à Dom 2 Philips Respironics 2 Sociedad Española de Neumología y Cirugía Torácica 2 Wissenschaftliches Institut Bethanien e.V 2 Albert Einstein Healthcare Network 1 Assiut University 1 Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche 1 Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil 1 Breas Medical S.A.R.L. 1 Corporacion Parc Tauli 1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1 Hospital Sao Joao 1

Trial status mix

COMPLETED24

TERMINATED8

UNKNOWN7

WITHDRAWN4

Phase mix

NA26

PHASE32

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.